These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 29845263)

  • 1. Novel triple‑positive markers identified in human non‑small cell lung cancer cell line with chemotherapy-resistant and putative cancer stem cell characteristics.
    Satar NA; Fakiruddin KS; Lim MN; Mok PL; Zakaria N; Fakharuzi NA; Abd Rahman AZ; Zakaria Z; Yahaya BH; Baharuddin P
    Oncol Rep; 2018 Aug; 40(2):669-681. PubMed ID: 29845263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
    Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
    BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGCG inhibits CSC-like properties through targeting miR-485/CD44 axis in A549-cisplatin resistant cells.
    Jiang P; Xu C; Chen L; Chen A; Wu X; Zhou M; Haq IU; Mariyam Z; Feng Q
    Mol Carcinog; 2018 Dec; 57(12):1835-1844. PubMed ID: 30182373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic Roles of Curcumin in Sensitising the Cisplatin Effect on a Cancer Stem Cell-Like Population Derived from Non-Small Cell Lung Cancer Cell Lines.
    Abdul Satar N; Ismail MN; Yahaya BH
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33670440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines.
    Baharuddin P; Satar N; Fakiruddin KS; Zakaria N; Lim MN; Yusoff NM; Zakaria Z; Yahaya BH
    Oncol Rep; 2016 Jan; 35(1):13-25. PubMed ID: 26531053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
    Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
    Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity.
    Cortes-Dericks L; Froment L; Boesch R; Schmid RA; Karoubi G
    BMC Cancer; 2014 Apr; 14():304. PubMed ID: 24884875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ALDH1⁺ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics.
    Li D; Zhang T; Gu W; Li P; Cheng X; Tong T; Wang W
    Oncol Rep; 2015 May; 33(5):2291-8. PubMed ID: 25760144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells.
    Yao W; Wang L; Huang H; Li X; Wang P; Mi K; Cheng J; Liu H; Gu C; Huang L; Huang J
    BMC Cancer; 2020 Apr; 20(1):315. PubMed ID: 32293355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
    Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
    J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NEAT1 contributes to the CSC-like traits of A549/CDDP cells via activating Wnt signaling pathway.
    Jiang P; Xu H; Xu C; Chen A; Chen L; Zhou M; Haq IU; Wu X; Mariyam Z; Feng Q
    Chem Biol Interact; 2018 Dec; 296():154-161. PubMed ID: 30291867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells.
    Quan YH; Lim JY; Choi BH; Choi Y; Choi YH; Park JH; Kim HK
    Cancer Chemother Pharmacol; 2019 Mar; 83(3):399-410. PubMed ID: 30515553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Increased expression of acetaldehyde dehydrogenase in cisplatin-resistant human lung adenocarcinoma A549/DDP cells].
    He J; Song X; Yu L; Li J; Qiao Z; Jiu R; Yu B; Liu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May; 31(5):625-9. PubMed ID: 25940289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of Notch3 inhibits the stem-like property and is associated with ALDH1A1 and CD44 via autophagy in non-small lung cancer.
    Ma Y; Li M; Si J; Xiong Y; Lu F; Zhang J; Zhang L; Zhang P; Yang Y
    Int J Oncol; 2016 Jun; 48(6):2349-58. PubMed ID: 27035162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
    Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
    Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC.
    MacDonagh L; Gray SG; Breen E; Cuffe S; Finn SP; O'Byrne KJ; Barr MP
    Cancer Lett; 2018 Aug; 428():117-126. PubMed ID: 29653268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinoma.
    Zhao M; Zhang Y; Zhang H; Wang S; Zhang M; Chen X; Wang H; Zeng G; Chen X; Liu G; Zhou C
    Lung Cancer; 2015 Feb; 87(2):98-106. PubMed ID: 25512094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity.
    Wang L; Liu X; Ren Y; Zhang J; Chen J; Zhou W; Guo W; Wang X; Chen H; Li M; Yuan X; Zhang X; Yang J; Wu C
    Cell Death Dis; 2017 Apr; 8(4):e2746. PubMed ID: 28406482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549.
    Roudi R; Madjd Z; Ebrahimi M; Samani FS; Samadikuchaksaraei A
    Cell Mol Biol Lett; 2014 Mar; 19(1):23-36. PubMed ID: 24363164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.